Icotyde (Icotrokinra Hydrochloride)

Icotyde (Icotrokinra hydrochloride) is an interleukin-23 (IL-23) receptor antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy.

Recommended Dosage:
The recommended dosage of Icotyde is 200 mg administered orally once daily. Administer this therapeutic drug upon waking on an empty stomach with water. Wait at least 30 minutes after taking Icotyde before eating food. Swallow the tablets whole, without crushing, splitting, or chewing them.
If a patient misses a dose, instruct patients to take the missed dose as quickly as possible with a return to the normal dosing schedule the following day.

• Treatment with Icotyde may weaken immune defenses, increasing the probability of serious bacterial, viral, or fungal infections. Monitor for fever, cough, wounds, or fatigue. Avoid exposure to contagious illnesses. Ask for medical care immediately if symptoms worsen or persist during treatment.
• Screen for latent tuberculosis (TB) before starting treatment with this medicine. This drug can reactivate dormant infection. Watch for persistent cough, night sweats, weight loss, or fever. Consider prophylactic therapy when required and avoid starting therapy during active, untreated tuberculosis (TB) disease in all patients.
• Avoid live vaccines during Icotyde therapy because of infection risk and reduced response. Update routine vaccinations before starting therapy when possible. Inactivated vaccines may be used, but effectiveness can be diminished; consult a healthcare professional for appropriate timing and selection.
• Limited human data exist; animal studies may show potential fetal harm. Use this medicinal product only if the benefits outweigh the risks. Discuss contraception during treatment and for a recommended period after. Inform your clinician immediately if pregnancy occurs or is planned currently.
• It is unknown whether Icotyde passes into human milk. Because of potential adverse effects in the infant, consider discontinuing breastfeeding or the drug. Monitor infants for infections or unusual symptoms if exposure occurs, and seek medical advice promptly.

What documents are required to import ICOTYDE® to India?

ICOTYDE (icotrokinra hydrochloride) tablets may be imported by patients or government hospitals in the patients’ names only.

• The following documentation is required to import the product:
• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is ICOTYDE® available in India?

ICOTYDE (icotrokinra hydrochloride tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) facilitates the import of cancer medicines under named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Icotyde in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Icotyde price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

ICOTYDE can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ICOTYDE (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact us at WhatsApp: +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for Icotyde cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ICOTYDE (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Icotyde®?

Icotrokinra hydrochloride is the Generic Name for the trade name drug Icotyde®.

What is the Manufacturer’s Name of Icotyde®?

Icotyde® is manufactured by Janssen Biotech, Inc

Is Icotyde® approved by the FDA?

Yes. Icotyde® is approved by the FDA. Date of first approval: March 17, 2026.

What strengths and dosage forms are available for Icotyde®?

Icotyde® is available as Tablets: 200 mg for oral administration.

What are the most common side effects of Icotyde® Tablets?

The most commonly reported side effects of Icotyde are cough, headache, nausea, fungal infection, and fatigue.

How does Icotyde Import in India work?

Icotyde Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Icotyde supplier in India?

Indian Pharma Network is a trusted Icotyde supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Icotyde® Tablet cost in India?

Icotyde® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Icotyde prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Icotyde cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Icotyde® Tablets be available in SAARC countries?

Apart from Gulf countries, Icotyde® Tablets can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Icotyde® Tablets in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Icotyde® Tablets online in India?

Yes, one can buy Icotyde in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Icotyde® Tablets through legal channels.

Who is an authorized Icotyde importer in India?

Indian Pharma Network acts as an Icotyde importer in India, assisting with Named Patient Import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

What are the storage conditions of Icotyde® Tablets?

Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). Store this drug in the original package to protect from moisture. Do not discard desiccant.